Genetic Signatures Ltd has released a press release.
Positive Trial Results Presented at ECCMID
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
Story so far
Earlier from Genetic Signatures
- Appendix 4D and Half Year Financial Statements
- 2017 AGM Presentation
- Appendix 4E and 2017 Financial Report
- Regulatory and Patent approval
- Results of Flavivirus Clinical Trial
Later from Genetic Signatures
- TGA registration for superbug detection kits
- Major Customer Contract Signed, New Kit and Instrument
- Update to major customer contract announcement
- Investor Presentation
- Additional Tax Incentive from understatement FY17 R&D Claim
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures